Finance

Lists
BTAIQ:OTCMKTS
BioXcel Therapeutics Inc
$0.074
0.00%
(0.00) 1D
$0.042
-42.90% (-0.032)
Pre-market
Closed: Sep 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BTAIQ...
Mkt. cap
2.27M
Avg. vol.
11.75M
Volume
0.00
52-wk high
$4.29
52-wk low
$0.07
EPS
-$3.78
Beta
0.19
Shares outstanding
31.30M
No. of employees
29
Mkt. cap
2.27M
Avg. vol.
11.75M
Volume
0.00
52-wk high
$4.29
52-wk low
$0.07
EPS
-$3.78
Beta
0.19
Shares outstanding
31.30M
No. of employees
29
About BioXcel Therapeutics Inc
CEO-
Employees29
Founded2017
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
98.00K
256.00K
206.00K
182.00K
Cost of goods sold
11.00K
32.00K
283.00K
22.00K
Cost of revenue
11.00K
32.00K
283.00K
22.00K
Research and development expenses
8.74M
6.70M
2.96M
3.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.38M
3.80M
7.19M
7.19M
Operating expense
14.12M
10.51M
10.15M
10.35M
Total operating expenses
14.13M
10.54M
10.43M
10.38M
Operating income
-14.03M
-10.28M
-10.22M
-10.19M
Other non operating income
-12.55M
1.81M
1.52M
-394.00K
EBT including unusual items
-30.91M
-12.54M
-12.69M
-14.71M
EBT excluding unusual items
-30.72M
-12.54M
-12.69M
-14.71M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-30.91M
-12.54M
-12.69M
-14.71M
Net profit margin
-31,541.84%
-4,900.39%
-6,160.68%
-8,084.07%
Earnings per share
-2.16
-
-0.54
-0.49
Interest and investment income
236.00K
321.00K
211.00K
131.00K
Interest expense
-4.37M
-4.40M
-4.20M
-4.26M
Net interest expenses
-4.14M
-4.08M
-3.99M
-4.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.96M
-10.21M
-10.16M
-10.18M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps